[1]刘萍萍,贾龙,李应东,等.地龙降压胶囊联合西医常规治疗肝阳上亢型原发性高血压伴亚临床动脉硬化临床研究[J].中国中医药信息杂志,2018,25(4):24-27.[doi:10.3969/j.issn.1005-5304.2018.04.006]
 LIU Ping-ping,JIA Long,LI Ying-dong,et al.Clinical Study on Dilong Jiangya Capsule in Treatment of Essential Hypertension with Subclinical Atherosclerosis of Hyperactivity of Liver Yang Type[J].zhongguo zhongyiyao xinxi zazhi,2018,25(4):24-27.[doi:10.3969/j.issn.1005-5304.2018.04.006]
点击复制

地龙降压胶囊联合西医常规治疗肝阳上亢型原发性高血压伴亚临床动脉硬化临床研究

参考文献/References:

[1] CATENA C, COLUSSI G, URL-MICHITSCH M, et al. Subclinical carotid artery disease and plasma homocysteine levels in patients with hypertension[J]. J Am Soc Hypertens,2015,9(3):167-175.

[2] SCUTERI A, CUNHA P G, ROSEI E A, et al. Arterial stiffness and influences of the metabolic syndrome:a cross-countries study[J]. Atherosclerosis,2014,233(2):654-660.

[3] 杜贺,陈少萍.他汀类药物不良反应及相关因素的研究进展[J].中国心血管杂志,2014,19(6):463-466.

[4] 刘斌.地龙降压胶囊对自发性高血压大鼠的降压及血管保护作用研究[D].兰州:甘肃中医药大学,2017:35-39.

[5] 中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华心血管病杂志,2011,39(7):579-611.

[6] 林铮,王振华,吴玉塘.臂踝脉搏波传导速度及踝臂指数对高血压患者早期动脉硬化的诊断价值[J].中国动脉硬化杂志,2015,23(11):1149- 1152.

[7] 黄彦生,王丽霞,王留义,等.阿托伐他汀对老年亚临床动脉粥样硬化患者单核细胞环氧化酶2活性的影响[J].中华老年心脑血管病杂志, 2013,15(10):1027-1029.

[8] 李静,蔡静波,王岚,等.高血压患者趾臂指数、肱踝脉搏波传导速度及踝臂指数在下肢动脉疾病诊断中的临床价值[J].实用老年医学, 2015(5):380-383.

[9] 中华人民共和国卫生部.中药新药临床研究指导原则:第三辑[M].北京,1997:3.

[10] 郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:731.

[11] 张兰娥,李清华,康白,等.地龙蛋白肽的成分分析及对血管紧张素转化酶活力的影响[J].天然产物研究与开发,2013,25(12):1740-1742.

[12] 骆小红,吴丽娜,燕虹,等.1065例中老年体检人群运动状况及其对PWV和ABI的影响[J].武汉大学学报:医学版,2013,34(4):573-576.

[13] 布热比艳?太来提,布娃加?吾守尔,玛依努尔?伊明艾山,等.原发性高血压患者踝臂指数、肱踝脉搏波传导速度与心脏结构、功能改变的相关性[J].中国动脉硬化杂志,2015,23(9):902-906.

相似文献/References:

[1]谢海波,孙敏,陈新宇.滋水清肝饮治疗原发性高血压临床观察[J].中国中医药信息杂志,2009,16(8):78.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(4):78.
[2]蒲朝晖,杨国栋,丁天玉,等.平降饮胶囊治疗220例原发性高血压临床观察[J].中国中医药信息杂志,2008,15(6):59.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(4):59.
[3]许红,蔡业峰.原发性高血压患者中医体质研究进展[J].中国中医药信息杂志,2011,18(6):104.[doi:10.3969/j.issn.1005-5304.2011.06.055]
 [J].zhongguo zhongyiyao xinxi zazhi,2011,18(4):104.[doi:10.3969/j.issn.1005-5304.2011.06.055]
[4]张宁,孙久林,董致郅,等.加味建瓴汤对原发性高血压患者胰岛素抵抗及血清白细胞介素-6水平的影响[J].中国中医药信息杂志,2011,18(12):19.[doi:10.3969/j.issn.1005-5304.2011.12.008]
 ZHANG Ning,SUN Jiu-lin,DONG Zhi-zhi,et al.Effect of Jiawei Jianling Tang on Insulin Resistance and Serum Interleukin-6 of Essential Hypertension Patients[J].zhongguo zhongyiyao xinxi zazhi,2011,18(4):19.[doi:10.3969/j.issn.1005-5304.2011.12.008]
[5]王国明,温峰云,李丽霞,等.瘢痕灸治疗原发性高血压病178例临床观察[J].中国中医药信息杂志,2006,13(1):55.
 [J].zhongguo zhongyiyao xinxi zazhi,2006,13(4):55.
[6]段学忠,孙西庆,王勇,等.益心降压胶囊对原发性高血压左室肥厚患者血清胰岛素样生长因子-1水平的影响[J].中国中医药信息杂志,2006,13(9):20.
 DUAN Xue-zhong,SUN Xi-qing,WANG Yong,et al.Effect of Yixin Jiangya Capsule on Serum Insulin-like Growth Factor-1 Level in Patients of Left Ventrecular Hypertrophy of Primary Hypertension[J].zhongguo zhongyiyao xinxi zazhi,2006,13(4):20.
[7]李霁,韩斐.中西医结合诊治儿童原发性高血压病探讨[J].中国中医药信息杂志,2012,19(10):92.[doi:10.3969/j.issn.1005-5304.2012.10.043]
[8]陈广垠,王丽娟,刘君,等.原发性高血压中医证型与相关危险因素的关系[J].中国中医药信息杂志,2012,19(11):16.[doi:10.3969/j.issn.1005-5304.2012.11.007]
 CHEN Guang-yin,WANG Li-juan,LIU Jun,et al.Relationship between TCM Syndrome Types and Related Risk Factors of Essential Hypertension[J].zhongguo zhongyiyao xinxi zazhi,2012,19(4):16.[doi:10.3969/j.issn.1005-5304.2012.11.007]
[9]王金玲,闫顺新,郭小舟.清肝解郁降压汤治疗原发性高血压伴焦虑状态40例[J].中国中医药信息杂志,2013,20(6):68.[doi:10.3969/j.issn.1005-5304.2013.06.027]
 [J].zhongguo zhongyiyao xinxi zazhi,2013,20(4):68.[doi:10.3969/j.issn.1005-5304.2013.06.027]
[10]陈贵海,武丽,臧知明,等.原发性高血压病和2型糖尿病血瘀证与非血瘀证患者抵抗素、脂联素水平比较[J].中国中医药信息杂志,2010,17(5):16.
 CHEN Gui-hai,WU Li,ZANG Zhi-ming,et al.Comparative Study on the Level of Resistin, Adiponectin between Blood Stasis Syndrome and Non-Blood Stasis Syndrome in Diabetic and Primary Hypertension Patients[J].zhongguo zhongyiyao xinxi zazhi,2010,17(4):16.

备注/Memo

基金项目:国家自然科学基金地区基金(81760798)

更新日期/Last Update:

2018-03-15